The global vasculitis market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period. The rising cases related to metabolic disorder and circulatory diseases such as peripheral artery disease is one of the prime factors affecting and driving the market. According to the American College of Cardiology across the globe, the incidence related to peripheral artery disease had been increasing at an increasing rate. In 2019, around 113 million cases were been observed of peripheral artery disease of which around 74,100 death occurred across the globe. This in turn is boosting the market for providing effective treatment to patients suffering from it in order to overcome diseases.
The demands of the vasculitis market are increasing its adoption of treatment and diagnosis through various testing across the globe. To gain on the opportunity key players operating in the global vasculitis market had been adopting strategies such as new launches. For instance, in March 2020, Novartis AG had introduced Beovu for the treatment of patients suffering from vasculitis.
To Request a Sample of our Report on Vasculitis Market: https://www.omrglobal.com/request-sample/vasculitis-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered-
- By Type
- By Diagnosis Tests
- By Therapeutic Class
- By End Users
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- BRISTOL-MYERS SQUIBB CO., ChemoCentryx, Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., and Novartis AG
Vasculitis Market
By Type
- Large Vessels
- Medium Vessels
- Small Vessels
By Diagnosis Tests
- Blood Test
- Urine Test
- Imaging Test
- Other
By Therapeutic Class
- Corticosteroids
- Immunosuppressants
- Biologics
By End Users
- Hospitals And Clinics
- Diagnosis Center
- Research Institutes
- Other
A full Report of Vasculitis Market is Available at: https://www.omrglobal.com/industry-reports/vasculitis-market
Vasculitis Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca
- BRISTOL-MYERS SQUIBB CO.
- Celltrion Healthcare Co.Ltd.
- ChemoCentryx, Inc.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc.
- Hikma Pharmaceuticals PLC
- Lilly
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- UCB SA
- Vifor Pharma Management Ltd.
- Viatris Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
